ArticleThe Lancet. Oncology2010

Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.

Fang-Hui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.